Granules Pharmaceuticals Inc. recalls Metformin Hydrochloride…
Granules Pharmaceuticals Inc. recalls Metformin Hydrochloride Extended-Release Tablets
- Published
- 15 Jan 2025
- Units affected
- 6,804 bottles
- Agency
- FDA
- Country
- United States
The hazard
Presence of Foreign Tablets/Capsules: A Paracetamol 500 mg tablet was found in a 1000-count bottle of Metformin HCL ER Tablets USP, 500 mg.
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Metformin Hydrochloride Extended-Release Tablets, USP, 500 mg, 1000-count bottles, Rx Only, Manufactured by: Granules India Limited, Hyderabad- 500 081, India, Manufactured for: Quallent Pharmaceuticals Health LLC, Grand Cayman, Grand Cayman Islands, NDC 82009-117-10
- Brand / company
- Granules Pharmaceuticals Inc.
- Codes / lots
- Lot #: 4911311A, Exp. Date: 11/2025
- Distribution
- Distributor in OH.
- Recall status
- Terminated
Source: U.S. Food and Drug Administration, published 15 Jan 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.